Free Trial
OTCMKTS:MEOBF

Mesoblast (MEOBF) Stock Price, News & Analysis

Mesoblast logo
$0.97 0.00 (0.00%)
As of 07/3/2025

About Mesoblast Stock (OTCMKTS:MEOBF)

Key Stats

Today's Range
$0.97
$0.97
50-Day Range
$0.96
$1.50
52-Week Range
$0.56
$5.34
Volume
N/A
Average Volume
133,747 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mesoblast Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
0th Percentile Overall Score

MEOBF MarketRank™: 

Mesoblast scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Mesoblast.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mesoblast is -3.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mesoblast is -3.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Mesoblast's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Mesoblast has a short interest ratio ("days to cover") of 446904, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Mesoblast has recently decreased by 0.17%, indicating that investor sentiment is improving.
  • Dividend Yield

    Mesoblast does not currently pay a dividend.

  • Dividend Growth

    Mesoblast does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Mesoblast has a short interest ratio ("days to cover") of 446904, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Mesoblast has recently decreased by 0.17%, indicating that investor sentiment is improving.
  • News Sentiment

    Mesoblast has a news sentiment score of -0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Mesoblast this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesoblast insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 27.35% of the stock of Mesoblast is held by institutions.

  • Read more about Mesoblast's insider trading history.
Receive MEOBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter.

MEOBF Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

MEOBF Stock Analysis - Frequently Asked Questions

Mesoblast's stock was trading at $2.20 on January 1st, 2025. Since then, MEOBF shares have decreased by 56.1% and is now trading at $0.9650.

Shares of MEOBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/06/2025
Next Earnings (Estimated)
7/29/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MEOBF
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:MEOBF) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners